BioCorRx (BICX) Net Cash Flow Growth (5y) (2015 - 2026)
BioCorRx (BICX) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn |
| 10 | BioCorRx | 10,406.16 | -374,763.84 | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.00% |
| Dec 31, 2025 | 15.49% |
| Sep 30, 2025 | 18.46% |
| Jun 30, 2025 | 16.79% |
| Mar 31, 2025 | 37.59% |
| Dec 31, 2024 | 15.92% |
| Sep 30, 2024 | 63.18% |
| Jun 30, 2024 | -15.09% |
| Mar 31, 2024 | 16.41% |
| Dec 31, 2023 | -35.99% |
| Sep 30, 2023 | 34.20% |
| Jun 30, 2023 | -14.99% |
| Mar 31, 2023 | 74.47% |
| Dec 31, 2022 | 15.05% |
| Sep 30, 2022 | 38.87% |
| Jun 30, 2022 | 34.40% |
| Mar 31, 2022 | -39.65% |
| Dec 31, 2021 | -66.17% |
| Sep 30, 2021 | 15.31% |
| Jun 30, 2021 | -25.76% |